Home › Free Stock Grades › CRVS
Corvus Pharmaceuticals, Inc. (CRVS) Stock Grade
CRVS · Healthcare
A+
Market Cap
$608.0M
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Corvus Pharmaceuticals, Inc.'s fundamentals
Corvus Pharmaceuticals is a biotechnology company with a market capitalization of $608.0 million that reported zero year-over-year revenue growth in its latest period. The company posted a net loss in its most recent annual statement, reflected in a net margin of 0.0%, and does not currently pay a dividend. Standard profitability metrics like P/E ratio and return on equity are not applicable due to the company's loss-making status.